- Home
- AUTL vs TGB Comparison
AUTL vs TGB Comparison
Compare AUTL & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | TGB |
|---|---|---|
| Founded | 2014 | 1966 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 2.1B |
| IPO Year | 2025 | 2002 |
Fundamental Metrics
Financial Performance| Metric | AUTL | TGB |
|---|---|---|
| Price | $1.61 | $6.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $8.50 | ★ $9.50 |
| AVG Volume (30 Days) | 1.4M | ★ 4.5M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | $71.94 |
| Revenue Next Year | $53.96 | $26.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $2.15 |
| 52 Week High | $2.70 | $9.25 |
Technical Indicators
Market Signals| Indicator | AUTL | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 43.93 |
| Support Level | $1.25 | $6.83 |
| Resistance Level | $1.73 | $7.96 |
| Average True Range (ATR) | 0.10 | 0.38 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 59.72 | 2.80 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.